Taisho Pharmaceutical Becomes Official Partner of the Japan Swimming Federation's National Team

Taisho Pharmaceutical Co., Ltd. [Headquarters: Toshima-ku, Tokyo; President: Shigeru Uehara] (hereinafter 'the Company') became an official partner of the Japan Swimming Federation (JAQUA) national team effective April 1, 2026. As the core organization leading the Japanese swimming world, JAQUA promotes the development of top athletes competing on the world stage and the popularization and development of the sport. It is a member of World Aquatics, the Japan Sports Association, and the Japanese Olympic Committee, opening up the future of Japanese sports and people's potential through swimming. The Company believes that sports lead to the development of healthy bodies and sound minds, and supports the development of sports culture. We believe that by supporting sports culture, the number of sports participants and fans will increase, contributing to the development of the sport. Through this official partnership with JAQUA, we will support those who are working positively toward their dreams and goals, and contribute to the development of sports culture. In addition, on Sunday, June 21, 2026, we will sponsor the OWS Oceans Cup 2026, held at Hojo Beach in Tateyama City, Chiba Prefecture, as a top partner for the Japan national Open Water Swimming (OWS) team. 'Lipovitan D' (a designated quasi-drug) sold by the Company is engaged in communication activities to support people who are working positively toward their dreams and goals. We will continue to support the development of sports through Lipovitan, and will continue to carry out various support activities for people who are working positively toward their dreams and goals.